Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Clinique Ovo
Age
18–45
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Women between 18-45 years included
First ovarian stimulation cycle only
Patients who used mixed protocols combining menotropin and follitropin alfa or delta
Patients whose Rekovelle doses were prescribed using the algorithm based on AMH and weight.
You may not be if
Patients who did not follow the algorithm to determine follitropin delta dosing and who required dose adjustments during the stimulation
Patients who took concomitant treatment, such as corticosteroids, low molecular weight heparin, nonsteroidal anti-inflammatory drugs, recombinant LH or intra-vaginal vasodilators